Elif Oral, MD, discusses her recent presentation at ENDO 2026 covering a phase 4 trial of the immunogenicity of metreleptin in this rare disease.
Elif Oral, MD
Advertisement
Elif Oral, MD, is a professor in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan.
Articles by Elif Oral, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
What Are Some Clinical Pearls in Pediatric Dermatology? With Lisa Swanson, MD
2
Plasma EV Analysis Identifies Proteins Associated With T1D Risk, With Ernesto Nakayasu, PhD
3
Diabetes Increases Mortality Risk Across All Major Organ Transplants
4
Looking Beyond TSH in Hypothyroidism Management, With Rosemarie Lajara, MD
5